Bionexus Gene Lab Corp Makes History With Ethereum-Focused Treasury Strategy
Nasdaq-listed Bionexus Gene Lab Corp (BGLC) has approved a treasury strategy centered on ethereum. Wyoming Blockchain Laws Hailed Bionexus Gene Lab Corp (BGLC), a technology and healthcare-focused company incorporated in...
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This ethereum story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on Bitcoin NewsRelated market context
Strategy Sells 3,588 Bitcoin to Fund Dividends as Saylor’s Treasury Model Meets Its First Real Test
Strategy (MSTR), the Michael Saylor–led company that turned corporate bitcoin accumulation into a Wall Street phenomenon, disclose...
Trump-Backed American Bitcoin (ABTC) Pushes Treasury Past 8,000 BTC
Bitcoin Magazine Trump-Backed American Bitcoin (ABTC) Pushes Treasury Past 8,000 BTC American Bitcoin Corp (Nasdaq: ABTC) has move...
42,197 ETH Acquired as Bitmine Builds $11.1B Crypto Treasury While Strategy Sells
Institutional crypto investors received two sharply different capital allocation signals Monday as Bitmine Immersion Technologies...
Strategy (MSTR) Sells 3,588 Bitcoin to Cover Preferred Dividends
Bitcoin Magazine Strategy (MSTR) Sells 3,588 Bitcoin to Cover Preferred Dividends Strategy sold 3,588 bitcoin for $216 million to...
Strategy Sold $216M in Bitcoin but Still Holds 843,775 BTC as Cash Reserve Tops $2.5B
Key Takeaways: Between 29th and 5th June, Strategy had sold 3,588 BTC worth of approximately $216 million. The funds from the sale...
Strategy dumps 3,500 BTC in largest sale… yet
Michael Saylor’s Strategy (formerly MicroStrategy) has sold 3,588 BTC for $216 million. His average sale price was approximately $...